Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group

Affiliations

• ¹ Y.Y. Leung, MB ChB, MD, Duke-NUS Medical School, Singapore, Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; [email protected].
• ² W. Tillett, BSc, MB ChB, PhD, Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK.
• ³ M. de Wit, PhD, GRAPPA Patient Research Partner, Amsterdam, the Netherlands.
• ⁴ A.M. Orbai, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
• ⁵ L.C. Coates, MB ChB, PhD, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
• ⁶ O. FitzGerald, MD, Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.
• ⁷ P.S. Helliwell, MD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
• ⁸ V. Strand, MD, Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA.
• ⁹ P.J. Mease, MD, Rheumatology Research, Swedish Medical Center/Providence St. Joseph Health and University of Washington School of Medicine, Seattle, Washington, USA.
• ¹⁰ N. Goel, MD, GRAPPA Patient Research Partner, and Therapeutic Area Head of Rheumatology, TrialSpark, and Duke University School of Medicine, Durham, North Carolina, USA.
• ¹¹ R. Christensen, MSc, PhD, Section for Biostatistics and Evidence-Based Research, The Parker Institute, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, and Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Odense University Hospital, Odense, Denmark.
• ¹² J.F. Merola, MD, MMSc, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.
• ¹³ C.A. Lindsay, PharmD, GRAPPA Patient Research Partner, Prosper, Texas, USA, employed by Arcutis Biotherapeutics Inc.
• ¹⁴ A. Ogdie, MD, MSCE, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
• ¹⁵ L. Gossec, MD, PhD, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, and AP-HP, Pitié-Salpêtrière Hospital, Rheumatology Department, Paris, France.
• ¹⁶ D.D. Gladman, MD, University of Toronto, Schroeder Arthritis Institute, Krembil Research Institute, and Psoriatic Arthritis Program, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada.